About Align Technology, Inc.
Align Technology, Inc. (ALGN) has been publicly traded since 2001, making it a 25-year-old public company. It operates in the Medical Instruments & Supplies industry within the Healthcare sector. The company is headquartered in Tempe, United States and employs approximately 20,290 people. With a market capitalization of $12 billion, ALGN is a large established company.
Key Statistics
- Current Price
- $164.23
- Market Cap
- $11.78B
- 52-Week High
- $208.31
- 52-Week Low
- $122.00
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
$1,000 Invested
Monthly Returns Heatmap
Annual Returns
| Year | Return | Start | End |
|---|---|---|---|
| 2026 | +5.17% | $156.15 | $164.23 |
| 2025 | -25.11% | $208.51 | $156.15 |
| 2024 | -23.90% | $274.00 | $208.51 |
| 2023 | +29.92% | $210.90 | $274.00 |
| 2022 | -67.91% | $657.18 | $210.90 |
| 2021 | +22.98% | $534.38 | $657.18 |
| 2020 | +91.51% | $279.04 | $534.38 |
| 2019 | +33.24% | $209.43 | $279.04 |
| 2018 | -5.74% | $222.19 | $209.43 |
| 2017 | +131.13% | $96.13 | $222.19 |
| 2016 | +45.98% | $65.85 | $96.13 |
| 2015 | +17.78% | $55.91 | $65.85 |
| 2014 | -2.15% | $57.14 | $55.91 |
| 2013 | +105.91% | $27.75 | $57.14 |
| 2012 | +16.94% | $23.73 | $27.75 |
| 2011 | +21.44% | $19.54 | $23.73 |
| 2010 | +9.65% | $17.82 | $19.54 |
| 2009 | +103.66% | $8.75 | $17.82 |
| 2008 | -47.54% | $16.68 | $8.75 |
| 2007 | +19.40% | $13.97 | $16.68 |
| 2006 | +115.92% | $6.47 | $13.97 |
| 2005 | -39.81% | $10.75 | $6.47 |
| 2004 | -34.89% | $16.51 | $10.75 |
| 2003 | +498.19% | $2.76 | $16.51 |
| 2002 | -38.67% | $4.50 | $2.76 |
Valuation
ALGN currently trades at a trailing P/E ratio of 29.1, which is considered high relative to the broader market. The forward P/E of 13.4 suggests analysts expect earnings to be lower in the coming year. The price-to-book ratio stands at 2.9. The price-to-sales ratio is 2.9.
Dividends
Align Technology, Inc. does not currently pay a dividend, choosing to reinvest earnings back into the business for growth.
Risk & Volatility
ALGN has a beta of 1.82, indicating it is significantly more volatile than the overall market. The stock's 52-week range is $122.00 to $208.31, and it currently trades in the lower half of its 52-week range.
Analyst Ratings
Based on 14 analyst opinions, ALGN has a consensus "buy" rating. The average price target of $201.57 suggests 22.7% upside from current levels.
Frequently Asked Questions
What does Align Technology, Inc. do? ▼
Align Technology, Inc. is a Medical Instruments & Supplies company operating in the Healthcare sector. The company is headquartered in Tempe, United States.
What sector is ALGN in? ▼
ALGN operates in the Healthcare sector, specifically in the Medical Instruments & Supplies industry.
When did ALGN go public? ▼
Align Technology, Inc. went public in 2001, making it a 25-year-old public company as of 2026.
How much would $1,000 invested in ALGN 5 years ago be worth today? ▼
A $1,000 investment in ALGN five years ago would be worth approximately $318 today, representing a -68.2% return.
Does ALGN pay dividends? ▼
No, Align Technology, Inc. does not currently pay a dividend. The company reinvests its earnings into growth.
What is ALGN's market cap? ▼
Align Technology, Inc. has a market capitalization of $12 billion, classifying it as a large-cap company.
What is ALGN's P/E ratio? ▼
ALGN has a trailing P/E ratio of 29.1 and a forward P/E of 13.4, which measures how much investors are paying per dollar of earnings.
Is ALGN a buy, hold, or sell? ▼
Based on 14 opinions, ALGN has a consensus "buy" rating. The average price target is $201.57.
Last updated: 3/14/2026